Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Leinco Technologies Inc Anti-Human CD20 (MS4A1, B1, Bp35) In Vivo PLATINUM; Clone 2H7; Isotype: Mouse IgG2b κ
SDP

Supplier:  Leinco Technologies Inc C1651100 MG

Encompass_Preferred

Specificity: This antibody recognizes an epitope on HumanCD20. Antigen Distribution: CD20 is present on human pre B lymphocytes and on B lymphocytes, except on plasma cells, and is synchronous with the expression of surface IgM. It is also expressed in some follicular dendritic cells and at low levels on a T cell subset. Background: This antigen is involved in B cell activation and is associated with various Src family kinases. Therapy with antibodies against CD20 is a widely used regimen in the treatment of all B cell lymphomas and leukemias. Applications: (WB, FA) Literature also indicates this clone can be used for in vivo B cell depletion, IHC, IP and Flow Cytometry. Leinco’s In vivo GOLDTM and In vivo PLATINUMTM functional antibodies are manufactured in an animal free facility using only In vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.

Catalog No. 50-190-5837


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.